Q3 2024 Holdings
Filed 2024-11-14 | 109 holdings | $3.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $172.0M | 294,250 | 5.6% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $132.6M | 270,000 | 4.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $126.6M | 233,500 | 4.1% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $125.8M | 142,000 | 4.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $109.9M | 1,978,272 | 3.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $108.2M | 939,000 | 3.5% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $78.2M | 1,147,500 | 2.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $71.1M | 768,776 | 2.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $68.8M | 250,000 | 2.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $65.5M | 4,684,476 | 2.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $64.3M | 1,228,093 | 2.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $61.6M | 1,580,488 | 2.0% |
| Freshpet Inc(FRPT) | COM | 358039105 | $61.1M | 446,500 | 2.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $58.5M | 2,070,000 | 1.9% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $55.8M | 263,062 | 1.8% |
| Phreesia Inc(PHR) | COM | 71944F106 | $52.0M | 2,282,500 | 1.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $51.8M | 1,316,477 | 1.7% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $51.7M | 815,000 | 1.7% |
| Penumbra Inc(PEN) | COM | 70975L107 | $51.5M | 265,000 | 1.7% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $50.4M | 167,750 | 1.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $49.9M | 683,344 | 1.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $49.7M | 1,049,386 | 1.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $48.5M | 325,000 | 1.6% |
| Humana Inc(HUM) | COM | 444859102 | $46.9M | 148,000 | 1.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $46.7M | 1,063,910 | 1.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $45.8M | 1,009,945 | 1.5% |
| Merus N V | COM | N5749R100 | $44.6M | 892,549 | 1.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $44.0M | 429,994 | 1.4% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $39.2M | 9,534,170 | 1.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $38.5M | 460,000 | 1.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $38.4M | 307,500 | 1.2% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $38.1M | 576,900 | 1.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $37.5M | 1,103,778 | 1.2% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $35.8M | 9,096,800 | 1.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $35.1M | 524,000 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $34.8M | 1,221,309 | 1.1% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $31.8M | 1,315,673 | 1.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $31.2M | 134,000 | 1.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $31.1M | 699,389 | 1.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $29.5M | 397,500 | 1.0% |
| Align Technology Inc(ALGN) | COM | 016255101 | $29.1M | 114,500 | 0.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $27.5M | 3,622,358 | 0.9% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $27.4M | 130,000 | 0.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $26.8M | 933,399 | 0.9% |
| Azenta Inc(AZTA) | COM | 114340102 | $25.8M | 532,500 | 0.8% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $24.8M | 508,932 | 0.8% |
| Warby Parker Inc(WRBY) | CL A COM | 93403J106 | $23.5M | 1,439,050 | 0.8% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $22.8M | 1,040,000 | 0.7% |
| Lifestance Health Group Inc(LFST) | COM | 53228F101 | $21.7M | 3,101,000 | 0.7% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $21.5M | 1,011,400 | 0.7% |